Update on ECMO for COVID-19 Weaning - V-A ECMO with Cardiogenic Shock Recombinant Activ. Factor VII

Vanderbilt University Medical Center; Department of CV Surgery: Faculty Forum
Update on ECMO for COVID-19: What have we learned?
Faculty:
J. Hoffman, MD,
Matt Warhoover, CCP,
A. Lepore, CCP

Tammy Sparacino Journal Club:
Early experience of pump-controlled retrograde trial off for weaning from veno-arterial extracorporeal membrane oxygenation (VA ECMO) in adult patients with cardiogenic shock.
Pump-controlled retrograde trial off has recently been introduced as an effective method for weaning from veno-arterial extracorporeal membrane oxygenation in pediatric patients. However, studies on pump-controlled retrograde trial off in adults are still lacking. Thus, this study aimed to examine the outcomes of pump-controlled retrograde trial off for weaning from veno-arterial extracorporeal membrane oxygenation in adult patients.

John Ingram Knowledge Nuggets:
Recombinant Activated Human Factor VII

Register and watch for free @ https://library.perfusioneducation.com
Get our Perfusion App - https://perfusioneducation.com/perfusion-app/
IV Dosage and Rate Calculator - https://mediweb.us/iv-medication-calculator/
Subscribe to our podcast:
Apple Podcasts - https://podcasts.apple.com/us/podcast/the-perfweb-podcast/id1549315399
Google Podcasts - https://www.google.com/podcasts?feed=aHR0cHM6Ly9mZWVkLnBvZGJlYW4uY29tL3BlcmZ3ZWIvZmVlZC54bWw%3D
Spotify - https://open.spotify.com/show/7FWOk2uUVKpzvqK1sxz3Lt
Visit our websites:
https://mediweb.us
https://perfweb.us
https://perfusioneducation.com
See Our Schedule:
https://perfweb.us/webinar-schedule/

Видео Update on ECMO for COVID-19 Weaning - V-A ECMO with Cardiogenic Shock Recombinant Activ. Factor VII канала PerfWeb